KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Major Shareholder Venrock Healthcare Capital Par Acquires 20,686 Shares
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par purchased 20,686 shares of the business’s stock in a transaction dated Wednesday, January 24th. The stock was purchased at an average price of $12.44 per share, for a total transaction of $257,333.84. Following the completion of the acquisition, the insider now […]
More Stories
Kaiser Aluminum (NASDAQ:KALU) Announces Earnings Results
Kaiser Aluminum (NASDAQ:KALU – Get Free Report) issued its earnings results on Wednesday. The industrial products company reported $0.51 EPS...
Ausbil Investment Management Ltd Purchases 1,721 Shares of Atmos Energy Co. (NYSE:ATO)
Ausbil Investment Management Ltd raised its stake in shares of Atmos Energy Co. (NYSE:ATO – Free Report) by 2.4% during...
Argent Capital Management LLC Buys 282 Shares of LCI Industries (NYSE:LCII)
Argent Capital Management LLC raised its stake in LCI Industries (NYSE:LCII – Free Report) by 14.5% during the third quarter,...
Ausbil Investment Management Ltd Buys 8,031 Shares of Modine Manufacturing (NYSE:MOD)
Ausbil Investment Management Ltd grew its position in shares of Modine Manufacturing (NYSE:MOD – Free Report) by 42.8% in the...
PG&E Co. (NYSE:PCG) Shares Acquired by Ausbil Investment Management Ltd
Ausbil Investment Management Ltd increased its position in shares of PG&E Co. (NYSE:PCG – Free Report) by 6.0% during the...
ESSA Bancorp Reports Financial Results for September 30, 2024
ESSA Bancorp, Inc., a Pennsylvania-based company, disclosed its financial outcomes for the period ending September 30, 2024. The announcement was...